Q3 FY26 results approved; new CFO from April 2026

Results View source PDF Explain this filing

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹327.00

prior close

₹325.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-0.1% vs market

Pharmaceuticals peers, median of 159sector-0.6%-0.3% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.5

15m

-1.1

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9-0.8-0.1-0.6-0.3

Next day

+1.9+1.8+0.1+1.1+0.7

+3.2+2.8+0.4+1.7+1.6

+0.9+2.3-1.3+1.3-0.4

-3.2+1.8-5.0+0.7-3.9

-2.7+0.3-3.0+0.0-2.7

-2.0+0.5-2.6-0.2-1.9

15d

-6.7-2.5-4.2-2.3-4.4

-9.4-6.3-3.1-4.4-5.1

-20.3-8.0-12.3-7.2-13.1

+15.6+8.3+7.3+2.6+13.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Themis Biosyn posted Q3 FY26 revenue of about 4,337 lakhs, up around 10 percent year-on-year from 3,952 lakhs. Nine month revenue rose to 12,159 lakhs from 11,306 lakhs. Net profit for Q3 was 1,246 lakhs versus 1,297 lakhs last year, while nine month profit dipped slightly to 3,579 lakhs. The board reappointed an independent director and approved Krupesh Patel as new CFO from April 1, 2026 as Bhavik Shah moves to a different role.

Likely market impact

Slightly lower profit YoY but steady operations. CFO transition and director reappointment are routine governance items.